/ Most Recent /
The Gout & Insulin Connection
Word is starting to spread that even in people whose blood glucose is within a healthy range, chronically elevated insulin can be ...
Mercury Pollution Found in Mayan Ruins
Archeologists have unearthed areas of mercury pollution beneath the soil where ancient Maya civilizations lived — the pollution is so ...
For a Long Life, Eat More Mushrooms and Algae
Scientists have discovered a food pairing that just might add years to your life. According to a large prospective cohort ...
Brain Food: How to Optimize Nutrition for Neurodiverse Children
Supporting the behavioral, emotional, and physical demands of children on the neurodiverse spectrum requires a multifaceted approach which can sometimes ...
Picky Eaters vs. Sensory Eaters in Neurodiverse Children
Most young children go through food jags — periods of picky eating where they will only eat one food or ...
Nicotinamide Mononucleotide NMN: what you need to know
Chronic disease in the United States, already highly prevalent, is expected to worsen over the next several decades among all ...
Lipid Energy Model
A large body of evidence supports the use of very low-carbohydrate ketogenic diets for weight loss, reversing metabolic syndrome, putting ...
Links to Fatty Liver Disease Discovered
A new study published in Chinese Medical Journal points to two new possible contributors to non-alcoholic fatty liver disease (NAFLD) ...
Meta-Analysis: CoQ10 Helps Fight Fatigue
Coenzyme Q10 (CoQ10) helps combat fatigue, says a new meta-analysis published in Frontiers in Pharmacology. Several clinical studies have suggested ...
/ Top Articles /
Sorry, we couldn't find any posts. Please try a different search.
/ Weight Loss /
Stopping GLP-1 Receptor Agonists… Why and How to Plan an “Exit Strategy” for Your Patients
In recent years, the pharmaceutical landscape has seen the emergence of glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) such as semaglutide and tirzepatide, offering promising outcomes in weight reduction for those struggling with obesity. Landmark trials demonstrated significant weight loss in obese individuals. ...
Acknowledging Gender Differences in Obesity Research
With the celebration of International Women’s Day on March 8th, it’s timely to review the differences in women’s health research and how that specifically affects investigations into treatments for overweight and obesity. Obesity and overweight—gender similarities and differences By 2022, 8 billion ...
Researchers Link Abdominal Fat to Brain Health in Men
According to the World Health Organization, some 55 million people globally suffer from Alzheimer’s disease or dementia. With 10 million new cases diagnosed annually, dementia has become the seventh leading cause of death worldwide, and those numbers are only likely to grow ...
Amarasate, An Extract of Bitter Hop Flowers Shown Effective For Weight Loss: The Science And Mode Of Action
With the massive interest in the use of glucagon-like peptide-1 (GLP-1) receptor agonists for the management of both Type 2 diabetes and obesity/overweight, it is timely to review the mode of action of these medications and that of an alternative GLP-1-stimulating nutraceutical. ...
Multiple Human Studies Show Significant Weight-Loss Benefits for Amarasate, A Proprietary Extract of Bitter Hops
A trio of studies performed in the past 5 years shows that a proprietary hops extract called Amarasate can help curb hunger and food cravings.
Supporting Integrative Practitioners Since 2013
